Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23122784 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Lapatinib Ditosylate and Capecitabine in Treating Patients With Stage IV Breast Cancer and Brain Metastases
Conditions: Breast Cancer;   Metastatic Cancer
Interventions: Drug: capecitabine;   Drug: lapatinib ditosylate;   Other: circulating tumor cell analysis;   Other: laboratory biomarker analysis

Indicates status has not been verified in more than two years